期刊文献+

血清肝细胞生长因子水平与乳腺癌转移的关系 被引量:3

Significance of Serum Concentration of Hepatocyte Growth Factor in Patients with Metastatic Breast Cancer
下载PDF
导出
摘要 目的:研究血清肝细胞生长因子(hepatocytegrowthfactory,HGF)与乳腺癌转移的关系。方法:应用双抗体夹心ELISA方法检测80例术后复发转移乳腺癌患者,50例术后无复发乳腺癌患者和20例献血员的血清肝细胞生长因子水平。结果:术后复发转移组血清HGF水平(0.90±0.52ng/ml)显著高于无复发组(0.38±0.30ng/ml;P<0.01)和正常对照组(0.22±0.36ng/ml;P<0.01)。肝转移组患者血清HGF水平(1.25±0.57ng/ml)显著高于其它转移组(0.78±0.48ng/ml;P<0.01)。多处转移组血清HGF水平(1.10±0.66ng/ml)显著高于其它转移组(0.78±0.48ng/ml;P<0.05)。结论:血清HGF水平与乳腺癌肝转移和多处转移发生密切相关。 Objective:To study the relationship between serum concentration of hepatocyte growth factor(HGF)and metastasis of breast cancer.Method:Serum HGF levels were determined in80patients with postoperatively metastatic breast cancer,50patients with postoperatively non-metastatic breast cancer,and20routine controls by using ELISA method.Result:Serum HGF level was significantly higher in recurrent group than in groups of non-metastasis and normal con-trols(P<0.01).Significantly higher level of serum HGF was observed in patients with liver metas-ta sis of breast cancer compared with those with other metastasis (P<0.01).Serum HGF level was sig nificantly higher in patients with multiple metastatic sites than in patients with other lesions(P<0.05).Conclusion:There was a closed relationship between serum HGF levels and liver metas-ta sis,multiple metastasis of breast cancer.
出处 《中国肿瘤临床》 CAS CSCD 北大核心 2003年第7期478-479,490,共3页 Chinese Journal of Clinical Oncology
基金 沈阳铁路局科研基金(编号:KW2001-05-086) 吉林省科委科技发展计划项目基金资助(编号:990568-1)
关键词 乳腺癌 肝细胞生长因子 转移 Breast cancer Hepatocyte growth factor Metastasis
  • 相关文献

参考文献10

  • 1[1]Seslar SP, Nakamura T, Byers SW. Regulation of fibroblast hepatocyte growth factor/scatter factor expression by human breast carcinoma cell lines and peptide growth factor[J]. Cancer Res, 1993,53(6):1233~1238
  • 2[2]Gao M, Fan S, Goldberg ID, et al. Hepatocyte Growth Factor/Scatter Factor blocks the mitochondrial pathway of apoptosis signaling in breast cancer cells[J]. J Biol Ghem, 2001,276(50) :47257 ~47265
  • 3[3]Harvey P, Clark IM, Jaurand M-C, et al. Hepatocyte growth factor/scatter factor enhances the invasion of mesothelioma cell lines and the expression of matrix metalloproteinases[J]. Br. J.Cancer, 2000,83(9):1145~1153
  • 4[4]Chakravarti A, Loeffler JS, Dyson NJ. Insulin-like Growth Factor Receptor I Mediates Resistance to Anti-EpidermalGrowth Factor Receptor Therapy in Primary Human Glioblastoma Ceils through Continued Activation of Phosphoinositide 3-Kinase Signaling[J]. Cancer Res, 2002,62(1):200~207
  • 5[5]Maehara N, Matsumoto K, Kuba K, et al. NK4, a fourkringle antagonist of HGF, inhibits spreading and invasion of human pancreatic cancer cells[J]. Br. J. Cancer, 2001, 84(6):864~873
  • 6[6]Nakamura T, Matsumoto K, Kiritoshi A, et al. Induction of hepatocyte growth factor in fibroblasts by tuinor-derived factors affects invasive growth of tumor cells: in vivo analysis of tumor-stromal interactions[J]. Cancer Res, 1997,57(15):3305 ~3313
  • 7[7]Jiang WG, Grimshaw D, Lane J, et al. A Hammerhead Ribozyme Suppresses Expression of Hepatocyte Growth Factor/Scatter Factor Receptor c-MET and Reduces Migration and Invasiveness of Breast Cancer Cells[J]. Clin Cancer Res, 2001,7(8):2555~2562
  • 8[8]Taniguchi T, Kitamura M, Arai K, et al. Increase in the circulating level of hepatocyte growth factor in gastric patients[J].Br. J. Cancer, 1997,75(5):673~677
  • 9[9]Yamashita J, Ogawa M, Yamashita S, et al. Immunoreactive hepatocyte growth factor is a strong and independent predictor of recurrence and survival in human breast cancer[J]. Cancer Res, 1994,54(7):1630~1633
  • 10[10]Shiota G, Okano J, Kawasaki H, et al. Serum hepatocyte growth factor levels in liver disease: clinical implications [J].Hepatology, 1995,21(1):106~112

同被引文献24

  • 1陈俊忠,徐嘉凤,叶红军.肝细胞生长因子及其受体与胃癌[J].医学综述,2005,11(7):613-614. 被引量:2
  • 2Yamashita J, Ogawa M, Beppu T. Immunoreactive hepatocyte growth factor is present in tissue extracts from human breast cancer but not in conditioned medium of human breast cancer cell lines[J]. Res commun Chem Pathol Pharmacol, 1993,82 (2) : 249.
  • 3Rosenthal EL, Johnson TM, Allen ED, et al. Role of the plasminogen activator matrix metall oproteinase Systems in epidermal growth factor and scatter factor stimulated invasion of carcinoma cells [J]. Cancer Res, 1998;58(22) :5221.
  • 4Eichbaum MH, de Rossi TM, Kaul S, et al. Serum levels of hepatocyte growth factor/scatter factor in patients with liver metastases from breast cancer[ J]. Tumour Biol, 2007,28( 1 ) :36.
  • 5Shyr-Ming Sheen-Chen, Yueh-Wei Liu, Hock-Liew Eng, et al. Serum Levels of Hepatocyte Growth Factor in Patients with Breast Cancer[ J]. Cancer Epidemiology Biomarkers & Prevention, 2005,14 (3) : 715.
  • 6NicolaMH, Bizon R, Machado J J, et al. Breast cancer micrometastases: different interactions of carcinoma cells with normal and cancer patients' bone marrow stromata[J]. Clin Exp Metastasis,2003,20(5):471.
  • 7连利娟.林巧稚妇科肿瘤学[M](第3版)[M].北京:人民卫生出版社,1999.317-323.
  • 8Wagatsuma S,Konno R,Sato S,et al.Tumor angiogenesis,hepatocyte growth factor,and c-met expression in endometrial carcinoma[J].Cancer,1998,82(3):520~530
  • 9Uchida D,Kawamata H,Omotehara F,et al.Role of HGF/c-met system in invasion and metastasis of oral squamous cell carcinoma cells in vitro and its clinical significance[J].Int J Cancer,2001,93 (4):489~496
  • 10Siegfried JM,Weissfeld LA,Luketich JD,et al.The clinical significance of hepatocyte growth factor for non-small cell lung cancer[J].Ann Thorac Surg,1998,66(6):1915~1918

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部